-
Study aim
-
Determining the effect of repeated letrozole dose on mature follicle and pregnancy rate in women with polycystic ovary syndrome resistant to the initial dose.
-
Design
-
A clinical trial with a control group with parallel, single-blind, randomized, phase 3, on 124 patients with polycystic ovary syndrome resistant to the initial dose of letrozole. The sealed envelope site was used for randomization.
-
Settings and conduct
-
Infertile women with polycystic ovary syndrome, referring to one of the private clinics in Rasht, who will be treated with letrozole in a dose of 5 mg/for 5 days. Then, on day 13-14 of the cycle, they will undergo transvaginal sonography, and if all follicles are less than 12 mm, they will be considered as not responding to letrozole.all these patients (resistant to the initial dose of letrozole) were randomly selected .They will be assigned to two intervention and control groups.study is single blinded.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: All infertile women with polycystic ovary syndrome resistant to letrozole primary treatment , with full consent to participate in the study, under the age of 35, With the indication of using oral medicine (not received 6 cycles of ovulation induction medication)
Exclusion criteria: Obstruction of the fallopian tubes, absence of a normal uterine cavity , ovarian cysts , metabolic diseases and any disease with a negative effect on ovulation, chronic heart, liver and kidney diseases, abnormal sperm analysis, using other ovulation induction drugs at the same time
-
Intervention groups
-
The intervention group, will take 2 letrozoles per day for 5 days from the 14th
(with repeated letrozole dose)
The control group:without receiving letrozole again
-
Main outcome variables
-
The size of mature follicle equal to 17 mm in ultrasound evaluation on day 22-23 of the cycle